TransCode Therapeutics Inc

NASDAQ:RNAZ   4:00:00 PM EDT
0.43
+0.03 (+7.47%)
7:58:03 PM EDT: $0.43 0.00 (0.00%)
Earnings Announcements

TransCode Therapeutics Reports Third Quarter 2022 Results, Provides Business Update

Published: 11/14/2022 22:11 GMT
TransCode Therapeutics Inc (RNAZ) - Transcode Therapeutics Reports Third Quarter 2022 Results; Provides Business Update.
Transcode Therapeutics Inc- Cash Was $8.8 Million at September 30, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.